Escherichia coli immunogens with improved solubility

Details for Australian Patent Application No. 2009215359 (hide)

Owner Novartis AG

Inventors Serino, Laura; Pizza, Mariagrazia; Gomes Moriel, Danilo; Fontana, Maria Rita

Agent FB Rice

Pub. Number AU-A-2009215359

PCT Pub. Number WO2009/104092

Priority MI2008A001249 09.07.08 IT; 61/030,902 22.02.08 US

Filing date 23 February 2009

Wipo publication date 27 August 2009

International Classifications

C07K 14/245 (2006.01) Peptides having more than 20 amino acids

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/104092 Priority application(s): WO2009/104092

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215360-Recoverable intra-uterine system

2009215342-Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore and other sandwich assays